Quoin Pharmaceuticals (QNRX) Interest & Investment Income (2022 - 2026)

Quoin Pharmaceuticals has reported Interest & Investment Income for 4 years, with the latest figure at $146775.0 in Q1 2026.

• Quarterly Interest & Investment Income rose 1.31% year-over-year to $146775.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $675661.0 (down 0.78% YoY) and the FY2025 annual result came in at $482081.0, down 13.68% from the prior year.
• Interest & Investment Income improved to $146775.0 in Q1 2026 per QNRX's latest filing, from $144872.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $196425.0 in Q3 2023 and troughed at $15132.0 in Q3 2022.
• A 4-year average of $131922.9 and a median of $146775.0 in 2026 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2023 and 2026: Interest & Investment Income soared 1198.08% in 2023, then climbed 1.31% in 2026.
• Over 4 years, Interest & Investment Income stood at $80613.0 in 2022, then surged by 143.66% to $196425.0 in 2023, then fell by 26.25% to $144872.0 in 2025, then advanced by 1.31% to $146775.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $146775.0, $144872.0, and $196425.0 for Q1 2026, Q1 2025, and Q3 2023 respectively.